E-098 Initial experience with the pipeline vantage flow diverter - vantage one study: six-month results, technical and clinical consideration

ConclusionThe new PVED reveals improved device visibility, ease of delivery and repositioning with precise distal opening in comparison to previous PED generations. Initial results demonstrate overall good device performance, safety profile and effectiveness. The implant requires a modified deployment technique for successful vessel wall apposition of the proximal stent as opposed to the previous generations of PED.ReferencesLylyk I, Scrivano E, Lundquist J, Ferrario A, Bleise C, Perez N, Lylyk PN, Viso R, Nella-Castro R, Lylyk P. Pipeline embolization devices for the treatment of intracranial aneurysms, single-center registry: long-term angiographic and clinical outcomes from 1000 aneurysms. Neurosurgery. 2021 Aug 16;89(3):443-449. doi: 10.1093/neuros/nyab183. PMID: 34098575; PMCID: PMC8374967.Chia GS, de Villiers L, Carraro do Nascimento V, et al. Safety and clinical effectiveness of pipeline shield device for intracranial aneurysms in an Australian Cohort (SCOPE-AUS). Stroke Vasc Interv Neurol. 2022;2(5):e000292.Rice H, Martínez Galdámez M, Holtmannspötter M, et al. J NeuroIntervent Surg 2020;12:1107-1112.Disclosures L. de Viliers: 1; C; Medtronic, Stryker, Microvention. 2; C; Medtronic, Stryker, Microvention. V. Carraro do Nascimento: 2; C; Medtronic, Stryker, Microvention. L. Domitrovic: None. H. Rice: 1; C; Medtronic, Stryker, Microvention. 2; C; Medtronic, Stryker, Microvention.
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: SNIS 20th annual meeting electronic poster abstracts Source Type: research